These studies demonstrate the value of targeting intrinsic and extrinsic pathways that can enhance tumor immunogenicity to NK cells as an approach to induce anti-PD1 responsiveness and control of CD8 + T cells in immunosuppressed or ‘cold’ tumors if the tumor mutational burden and neoantigen presentation are sufficiently high (Fig. 1). Here, CD8A is linked to neoplasm.